Generation and analysis of genetically defined liver carcinomas derived from bipotential liver progenitors
about
Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approachGrowth arrest and DNA damage 45G down-regulation contributes to Janus kinase/signal transducer and activator of transcription 3 activation and cellular senescence evasion in hepatocellular carcinomaHCV infection-associated hepatocellular carcinoma in humanized miceDLC1 is a chromosome 8p tumor suppressor whose loss promotes hepatocellular carcinomaSenescence and tumour clearance is triggered by p53 restoration in murine liver carcinomasHepatocellular Carcinomas Originate Predominantly from Hepatocytes and Benign Lesions from Hepatic Progenitor Cells.Differences in the properties and mirna expression profiles between side populations from hepatic cancer cells and normal liver cells.Cancer gene discovery in hepatocellular carcinomaTransient mTOR inhibition facilitates continuous growth of liver tumors by modulating the maintenance of CD133+ cell populations.An oncogenomics-based in vivo RNAi screen identifies tumor suppressors in liver cancerTumor induced hepatic myeloid derived suppressor cells can cause moderate liver damage.Identification of a therapeutic strategy targeting amplified FGF19 in liver cancer by Oncogenomic screeningTargeting cadherin-17 inactivates Wnt signaling and inhibits tumor growth in liver carcinomaA Sleeping Beauty mutagenesis screen reveals a tumor suppressor role for Ncoa2/Src-2 in liver cancer.A cluster of cooperating tumor-suppressor gene candidates in chromosomal deletionsSIP1 is a downstream effector of GADD45G in senescence induction and growth inhibition of liver tumor cells.In vivo RNAi screens: concepts and applications.Integrative oncogenomic approaches for accelerated cancer-gene discovery.The hippo-yes association protein pathway in liver cancerCombined hepatocellular and cholangiocarcinoma originating from the same clone: a pathomolecular evidence-based study.Regulation of accumulation and function of myeloid derived suppressor cells in different murine models of hepatocellular carcinoma.Mouse model of intrahepatic cholangiocarcinoma validates FIG-ROS as a potent fusion oncogene and therapeutic target.Decreased expression of Neurensin-2 correlates with poor prognosis in hepatocellular carcinoma.Genome-wide methylation analysis and epigenetic unmasking identify tumor suppressor genes in hepatocellular carcinoma.Modeling pathogenesis of primary liver cancer in lineage-specific mouse cell types.Developing better treatments in hepatocellular carcinoma.Current concepts of immune based treatments for patients with HCC: from basic science to novel treatment approaches.IAPs contain an evolutionarily conserved ubiquitin-binding domain that regulates NF-kappaB as well as cell survival and oncogenesisActivation of liver stromal cells is associated with male-biased liver tumor initiation in xmrk and Myc transgenic zebrafish.Organ size control is dominant over Rb family inactivation to restrict proliferation in vivo.Mutual epithelium-macrophage dependency in liver carcinogenesis mediated by ST18.IDH mutations in liver cell plasticity and biliary cancer.MicroRNA silencing of tumor suppressor DLC-1 promotes efficient hepatitis C virus replication in primary human hepatocytes.
P2860
Q24633776-9DF68B70-1B59-4F0E-9766-FB30D813A13CQ28295550-42CABF58-0ADF-40A1-94AE-3FFB4F8ADB7FQ28384465-8409903F-BE1A-4D4F-92F3-9C4A7AD9C63BQ28384558-21889C5C-80CE-4007-B24D-153F31229237Q29616243-A4176402-A802-4DEC-80C0-D3E4E9F40298Q33617469-1BE1D124-0D85-49FD-B83A-13201C02F12FQ33986171-325C382D-F6A9-45DA-AC92-DD5F0D401478Q34002120-3D3B92BB-7B4D-4AE2-B880-BF75068612BEQ34092485-D237A11A-313A-4191-A592-B6C915749869Q34345765-963E472A-A70F-421F-9920-86E6740CDDB4Q34525342-58DF16A6-681A-409A-9757-FA17F203D7EAQ34701235-22A8EDD3-CEF8-4796-AD53-635D758DE04DQ35893965-AE77BEC5-BB30-4306-992B-A6CA013C68AFQ35991536-CD199610-8A44-4448-B0CE-59984559BEB7Q35991696-7C7929A6-FAB0-4531-8D36-EBF1921E2391Q36545237-60F372AF-9F54-4972-B3DE-5AB8EEC455E4Q36736715-A3E78C0D-A3A8-48C5-9F4A-403C2893EC44Q37016832-FE391505-DB0E-437D-8E2F-46EBC019EE30Q37108727-3836D4B1-1237-44F9-9F48-8FA8E1A4A7BAQ37199349-D5A46120-FA5F-4911-B05A-BF1D996F27BBQ37248887-EE57777B-A210-468F-934A-F4F702C512A8Q37353061-FC4D507B-81C0-465C-B1B8-ABCDFB25E77EQ37386559-6A0B01CA-09FB-42BB-86F4-8C6F588F77E2Q37481324-58A720D9-9986-4449-AF79-EC2507440437Q37552414-F7FFE071-C101-4569-A598-480311196BBCQ37798817-878BECF9-F53F-4DD5-B586-E483250C8861Q38349665-7FD3193A-0151-4883-8CEC-DDB48F138961Q39927741-939B068A-AA5C-4C46-B4AE-91CB869651D5Q41606121-D6E9A5EE-3D5E-493A-90B9-D01E28198BE4Q41892098-C96B25C1-2EA9-4B7A-88B1-0EBA7236B932Q42289925-63CBDE96-28BE-453F-9A8B-442EF74999ECQ42594611-AE4CD6B9-AAA2-4807-9866-827F5D4928B3Q43000816-E5A8BFBA-2C3E-4840-BE1C-DFDB378EE3A6
P2860
Generation and analysis of genetically defined liver carcinomas derived from bipotential liver progenitors
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Generation and analysis of gen ...... bipotential liver progenitors
@ast
Generation and analysis of gen ...... bipotential liver progenitors
@en
type
label
Generation and analysis of gen ...... bipotential liver progenitors
@ast
Generation and analysis of gen ...... bipotential liver progenitors
@en
prefLabel
Generation and analysis of gen ...... bipotential liver progenitors
@ast
Generation and analysis of gen ...... bipotential liver progenitors
@en
P2093
P2860
P356
P1476
Generation and analysis of gen ...... bipotential liver progenitors
@en
P2093
C Cordón-Cardo
G J Hannon
M S Spector
P Flemming
P2860
P304
P356
10.1101/SQB.2005.70.059
P50
P577
2005-01-01T00:00:00Z